These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21847613)

  • 1. Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion.
    Teesalu K; Panarina M; Uibo O; Uibo R; Utt M
    Amino Acids; 2012 Feb; 42(2-3):1055-64. PubMed ID: 21847613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age.
    Maglio M; Tosco A; Paparo F; Auricchio R; Granata V; Colicchio B; Indolfi V; Miele E; Troncone R
    J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):43-8. PubMed ID: 19934769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies.
    Caja S; Myrsky E; Korponay-Szabo IR; Nadalutti C; Sulic AM; Lavric M; Sblattero D; Marzari R; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
    Scand J Gastroenterol; 2010 Apr; 45(4):421-7. PubMed ID: 20095873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.
    Scarpellini A; Germack R; Lortat-Jacob H; Muramatsu T; Billett E; Johnson T; Verderio EA
    J Biol Chem; 2009 Jul; 284(27):18411-23. PubMed ID: 19398782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
    Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic and functional characterisation of the heparin-binding peptides from human transglutaminase 2.
    Teesalu K; Uibo O; Uibo R; Utt M
    J Pept Sci; 2012 May; 18(5):350-6. PubMed ID: 22447354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential new mechanisms of placental damage in celiac disease: anti-transglutaminase antibodies impair human endometrial angiogenesis.
    Di Simone N; De Spirito M; Di Nicuolo F; Tersigni C; Castellani R; Silano M; Maulucci G; Papi M; Marana R; Scambia G; Gasbarrini A
    Biol Reprod; 2013 Oct; 89(4):88. PubMed ID: 23966323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific celiac disease antibodies in children on a gluten-free diet.
    Hogen Esch CE; Wolters VM; Gerritsen SA; Putter H; von Blomberg BM; van Hoogstraten IM; Houwen RH; van der Lely N; Mearin ML
    Pediatrics; 2011 Sep; 128(3):547-52. PubMed ID: 21859913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.
    Lortat-Jacob H; Burhan I; Scarpellini A; Thomas A; Imberty A; Vivès RR; Johnson T; Gutierrez A; Verderio EA
    J Biol Chem; 2012 May; 287(22):18005-17. PubMed ID: 22442151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue transglutaminase in celiac disease: role of autoantibodies.
    Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
    Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
    Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
    Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 2 in celiac disease: minireview article.
    Caputo I; D'Amato A; Troncone R; Auricchio S; Esposito C
    Amino Acids; 2004 Jul; 26(4):381-6. PubMed ID: 15290344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.
    Borrelli M; Maglio M; Korponay-Szabó IR; Vass V; Mearin ML; Meijer C; Niv-Drori H; Ribes-Koninckx C; Roca M; Shamir R; Troncone R; Auricchio R
    Clin Exp Immunol; 2018 Mar; 191(3):311-317. PubMed ID: 29114847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling.
    Wang Z; Collighan RJ; Pytel K; Rathbone DL; Li X; Griffin M
    J Biol Chem; 2012 Apr; 287(16):13063-83. PubMed ID: 22298777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
    Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
    Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
    Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
    Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
    Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
    Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.
    Tosco A; Aitoro R; Auricchio R; Ponticelli D; Miele E; Paparo F; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2013 Jan; 171(1):69-75. PubMed ID: 23199325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.